Cannabinoids Explained
Short answer: Cannabinoids are chemical compounds that interact with the body’s endocannabinoid system. More than 100 occur in cannabis. A few are intoxicating (delta-9 THC, delta-8 THC, HHC), most are not (CBD, CBG, CBN, CBDV), and their legal status in the US now depends on how they are produced as much as what they are.
Last reviewed: November 4, 2026. Federal hemp rules change on November 12 and December 11, 2026. See the 2026 hemp law explained. Educational information only — not medical or legal advice.
What cannabinoids do
Your body has an endocannabinoid system: receptors (mainly CB1 and CB2), the compounds your body makes to activate them (endocannabinoids such as anandamide), and enzymes that break those compounds down. The system is involved in appetite, sleep, mood, pain signaling and memory.
Plant cannabinoids — phytocannabinoids — interact with that system in different ways:
- Direct agonists bind the receptor and activate it. Delta-9 THC is the classic example.
- Weak or partial agonists bind less strongly. Delta-8 and HHC behave this way, which is why they are described as milder.
- Indirect modulators do not bind CB1 much at all but influence the system through other pathways. CBD is the main example.
This is why “CBD and THC are both cannabinoids” tells you almost nothing. They act differently, feel different, and are regulated differently.
Quick comparison
| Cannabinoid | Intoxicating? | Naturally in cannabis? | Federal hemp status after 2026 |
|---|---|---|---|
| Delta-9 THC | Yes, strongly | Yes, primary | Legal only within total-THC limits |
| THCA | No when raw; yes when heated | Yes, the main THC precursor | Counted in total THC from Dec 11 |
| Delta-8 THC | Yes, milder | Trace amounts | Commercial (synthesized) product loses status Dec 11 |
| Delta-10 THC | Yes, mild | Trace amounts | Synthesized product loses status Dec 11 |
| HHC | Yes | Trace only | Loses status Nov 12 |
| THCP | Yes, reportedly strong | Trace amounts | Synthesized product loses status Dec 11 |
| THCO | Yes | No | Loses status Nov 12 |
| THCV | Mild / disputed | Yes, trace | Synthesized product loses status Dec 11 |
| CBD | No | Yes | Not scheduled; isolate unaffected |
| CBG | No | Yes | Not scheduled |
| CBN | No | Yes, mostly as THC degrades | Not scheduled |
| CBDV | No | Yes, trace | Not scheduled |
“Trace amounts” is the crux of the legal change. A cannabinoid that exists in the plant in tiny quantities cannot be extracted commercially — so the version sold in stores is made in a lab. The 2026 law excludes those products from the definition of hemp.
Intoxicating cannabinoids
Delta-9 THC
The main intoxicating cannabinoid and the one most research has focused on. It binds CB1 strongly. Hemp-derived delta-9 is legal only within strict THC limits. Read the delta-9 guide.
Delta-8 THC
One double bond away from delta-9, weaker at CB1, and usually described as milder and clearer. Commercial delta-8 is synthesized from CBD, which is why it loses federal hemp status on December 11, 2026. Read the delta-8 guide.
HHC
Made by hydrogenating THC. More stable than delta-8 and roughly similar in strength, with a longer duration. Not naturally produced in commercial quantities, so it loses hemp status on November 12, 2026. Read the HHC guide.
THCO
THC with an acetate group attached. No natural source, very little human data, and inconsistent user reports. Loses hemp status on November 12, 2026. Read the THCO guide.
THCP
Reported to be far more potent than delta-9 at the receptor, though human data is minimal and product dosing is often unclear. Treat potency claims with caution. Read the THCP guide.
Delta-10 THC
A minor cannabinoid often described as gentler and more cerebral than delta-8. Very little research. Read the delta-10 guide.
THCV
Studied for appetite and metabolic effects. At low doses it is generally described as non-intoxicating; at high doses, users report a clear-headed stimulation. Read the THCV guide.
Delta-11 THC
A minor isomer with almost no published human research. Any confident claim about its effects is marketing, not science. Read the delta-11 guide.
THCH
A hexyl-chain cannabinoid, one carbon longer than delta-9 and one shorter than THCP. Reported higher CB1 affinity in lab work, but no controlled human studies. Read the THCH guide.
Non-intoxicating cannabinoids
CBD
The most studied non-intoxicating cannabinoid. It does not bind CB1 strongly and does not produce a high. The only cannabis-derived drug approved by the FDA — Epidiolex — is a CBD product, for specific seizure disorders. Read the CBD guide.
CBG
Often called the “mother cannabinoid” because many others derive from it in the plant. Research is early; it is generally described as non-intoxicating. Read the CBG guide.
CBN
Formed as THC degrades. Heavily marketed for sleep, but the human evidence for that claim is thin. It is not a substitute for a sedative and is not intoxicating in the way THC is. Read the CBN guide.
CBDV
A minor cannabinoid structurally related to CBD, under early study for seizure-related research. Not intoxicating. Read the CBDV guide.
The legal layer
Since 2018, the US has regulated cannabinoids by source plant and by delta-9 concentration rather than by molecule. The 2026 changes replace that with a total-THC standard and a per-container cap, and exclude cannabinoids that cannot be naturally produced.
Practical guides
- Does delta-8 show up on a drug test?
- How long does delta-8 stay in your system?
- Delta-8 dosage guide
- Delta-9 dosage guide
- CBD dosage guide
- Hemp laws by state
- THCA: the raw acid form of THC — and why heat turns it into THC
- How to choose a THCA product — COA, total-THC maths and the 2026 deadline
- All buying guides — how to evaluate a product before you buy
- How to read a lab report
- How the use-case categories work
How to evaluate any cannabinoid product
- Get the COA. A batch-specific certificate of analysis from an independent lab. It should match the package batch number.
- Check total THC, not just the headline cannabinoid. After December 11, 2026, the federal cap is 0.4 mg total THC per container.
- Check for residual solvents and reagents. This matters most for synthesized cannabinoids.
- Check the date against the law. A product’s legal status can change while it sits on a shelf.
- Check your state. State rules can be stricter than federal rules.
Browse products by cannabinoid: delta-8, delta-9, HHC, THCO, THCP, THCV, CBD, CBG and CBDV. THCA does not have its own product category in this catalog; read the THCA guide instead.
Frequently asked questions
What is the difference between CBD and THC?
CBD is not intoxicating and binds CB1 weakly. THC binds CB1 strongly and produces a high. They are different molecules with different effects and different legal treatment.
How many cannabinoids are there?
More than 100 have been identified in cannabis. Only a handful are sold commercially, and only a few have meaningful human research behind them.
Which cannabinoids are intoxicating?
Delta-9 THC, delta-8 THC, delta-10 THC, HHC, THCP and THCO are intoxicating. CBD, CBG, CBN and CBDV are not.
Are cannabinoids legal?
It depends on the cannabinoid, how it was produced, and your state. See the 2026 hemp law guide.
What is the endocannabinoid system?
A network of receptors, signaling molecules and enzymes involved in appetite, sleep, mood, pain and memory. Plant cannabinoids interact with it in different ways.
Sources
- National Academies, The Health Effects of Cannabis and Cannabinoids
- National Center for Complementary and Integrative Health, cannabis research summaries
- Public Law 119-37 §781; Public Law 119-103 §2019
Educational information only. Not medical or legal advice.